Sunshine Guojian Pharmaceutical Shanghai's (SHA:688336) net profit attributable to shareholders in the first half jumped 95% to 371.3 million yuan from 190.3 million yuan a year earlier, according to a Shanghai bourse filing on Friday.

Earnings per share increased year on year to 0.41 yuan from 0.21 yuan.

Operating revenue climbed 35% to 865.7 million yuan from 642 million yuan in the prior year.

The Chinese drugmaker also proposed a cash dividend payout of 0.42 yuan for every 10 shares to all shareholders.

The company's shares fell 2% during the afternoon trade.